Search for other papers by Merlin C Thomas in
Google Scholar
PubMed
Search for other papers by Brendon L Neuen in
Google Scholar
PubMed
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
Search for other papers by Stephen M Twigg in
Google Scholar
PubMed
Search for other papers by Mark E Cooper in
Google Scholar
PubMed
Department of Renal Medicine, St George Hospital, Sydney, NSW, Australia
Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Sunil V Badve in
Google Scholar
PubMed
, after a median follow-up of 16 months, the primary composite outcome was reduced by sotagliflozin compared with placebo (HR 0.74; 95% CI 0.63–0.88; P < 0.001). The MACE outcome (a composite of CV death, non-fatal myocardial infarction or stroke) was
Search for other papers by N Bergmann in
Google Scholar
PubMed
Search for other papers by F Gyntelberg in
Google Scholar
PubMed
Endocrine Unit, The National Research Centre for the Working Environment, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, DK-2730 Herlev, Denmark
Search for other papers by J Faber in
Google Scholar
PubMed
. Metabolic syndrome and risk of acute myocardial infarction a case–control study of 26,903 subjects from 52 countries . Journal of the American College of Cardiology 2010 55 2390 – 2398 . ( doi:10.1016/j.jacc.2009.12.053 ). 81 Dweck JS Jenkins SM
Search for other papers by Shi-en Fu in
Google Scholar
PubMed
Search for other papers by Rou-mei Wang in
Google Scholar
PubMed
Search for other papers by Xing-huan Liang in
Google Scholar
PubMed
Search for other papers by Jing Xian in
Google Scholar
PubMed
Search for other papers by Jie Pan in
Google Scholar
PubMed
Search for other papers by Xue-lan Chen in
Google Scholar
PubMed
Search for other papers by Cheng-cheng Qiu in
Google Scholar
PubMed
Search for other papers by Zhi-ping Tang in
Google Scholar
PubMed
Search for other papers by Ying-fen Qin in
Google Scholar
PubMed
Search for other papers by Hai-yan Yang in
Google Scholar
PubMed
Department of Endocrinology, The Affiliated Hospital of Guilin Medical University, Guilin, China
Search for other papers by Li-li Huang in
Google Scholar
PubMed
Search for other papers by Ya-qi Kuang in
Google Scholar
PubMed
Search for other papers by Yan Ma in
Google Scholar
PubMed
Search for other papers by Zuo-jie Luo in
Google Scholar
PubMed
Practice . ( https://doi.org/10.3760/cma.j.issn.1671-7368.2019.12.002 ) 9 Nilsson G Hedberg P Leppert J & Ohrvik J . Basic anthropometric measures in acute myocardial infarction patients and individually sex- and age-matched controls from the
Search for other papers by Henry Zelada in
Google Scholar
PubMed
Search for other papers by M Citlalli Perez-Guzman in
Google Scholar
PubMed
Search for other papers by Daniel R Chernavvsky in
Google Scholar
PubMed
Search for other papers by Rodolfo J Galindo in
Google Scholar
PubMed
K Ryden L Wedel H Birkeland K Bootsma A Dickstein K Efendic S Fisher M Hamsten A Herlitz J , Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on
INSERM U1018, Université Paris Sud, Centre for Research in Epidemiology and Population Health, Hôpital Paul Brousse, Bât 15/16, 16 Avenue Paul Vaillant Couturier, 94807 Paris, Villejuif Cedex, France
Search for other papers by Richard H Tuligenga in
Google Scholar
PubMed
of the ORIGIN trial . Lancet. Diabetes & Endocrinology 2014 2 562 – 572 . ( doi:10.1016/S2213-8587(14)70062-2 ). 17 Chatterjee S Sharma A Lichstein E Mukherjee D . Intensive glucose control in diabetics with an acute myocardial
Search for other papers by Hongyan Wang in
Google Scholar
PubMed
Search for other papers by Bin Wu in
Google Scholar
PubMed
Search for other papers by Zichuan Yao in
Google Scholar
PubMed
Search for other papers by Xianqing Zhu in
Google Scholar
PubMed
Search for other papers by Yunzhong Jiang in
Google Scholar
PubMed
Search for other papers by Song Bai in
Google Scholar
PubMed
(0%) Clavien IV 14 (5.3%) 4 (3.2%) Myocardial infarction 4 (1.6%) 0 (0%) Respiratory function failure 6 (2.1%) 2 (1.6%) Pulmonary embolism/deep vein thrombosis 1 (0.4%) 1 (0.8%) Stroke 2 (0.8%) 1
Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Signe Frøssing in
Google Scholar
PubMed
Department of Obstetrics & Gynecology, Herlev Gentofte Hospital, Copenhagen, Denmark
Search for other papers by Malin Nylander in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Caroline Kistorp in
Google Scholar
PubMed
Department of Obstetrics & Gynecology, Herlev Gentofte Hospital, Copenhagen, Denmark
Search for other papers by Sven O Skouby in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
released when vasopressin is activated. It is more stable for measurement than vasopressin itself and reflects vasopressin levels and thus responds to osmolality. Copeptin shows potential as a rule-out marker in combination with troponin in myocardial
Search for other papers by Hoda Gad in
Google Scholar
PubMed
Search for other papers by Einas Elgassim in
Google Scholar
PubMed
Department of Internal Medicine, Albany Medical Center Hospital, Albany, New York, USA
Search for other papers by Ibrahim Mohammed in
Google Scholar
PubMed
Search for other papers by Ahmad Yaser Alhaddad in
Google Scholar
PubMed
Search for other papers by Hussein Ahmed Hussein Zaky Aly in
Google Scholar
PubMed
Search for other papers by John-John Cabibihan in
Google Scholar
PubMed
Search for other papers by Abdulaziz Al-Ali in
Google Scholar
PubMed
Search for other papers by Kishor Kumar Sadasivuni in
Google Scholar
PubMed
Search for other papers by Aliyaa Haji in
Google Scholar
PubMed
Search for other papers by Neila Lamine in
Google Scholar
PubMed
Search for other papers by Adnan Khan in
Google Scholar
PubMed
Search for other papers by Ioannis N Petropoulos in
Google Scholar
PubMed
Search for other papers by Georgios Ponirakis in
Google Scholar
PubMed
Search for other papers by Alise Kalteniece in
Google Scholar
PubMed
Search for other papers by Maryam Ferdousi in
Google Scholar
PubMed
Search for other papers by Shazli Azmi in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Royal Liverpool and Broadgreen University NHS Hospital Trust, Liverpool, UK
Division of Endocrinology, Diabetes and Gastroenterology, University of Manchester, Manchester, UK
Search for other papers by Uazman Alam in
Google Scholar
PubMed
Search for other papers by Wajeeha Abuhelaiqa in
Google Scholar
PubMed
Search for other papers by Amin Jayyousi in
Google Scholar
PubMed
Search for other papers by Dabia AlMohanadi in
Google Scholar
PubMed
Search for other papers by Khaled Baagar in
Google Scholar
PubMed
Institute of Cardiovascular Medicine, University of Manchester, Manchester, UK
Search for other papers by Rayaz A Malik in
Google Scholar
PubMed
revascularization investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction . Circulation 2009 120 2529
Search for other papers by M Cherenko in
Google Scholar
PubMed
Search for other papers by N M Appelman-Dijkstra in
Google Scholar
PubMed
Search for other papers by A L Priego Zurita in
Google Scholar
PubMed
Search for other papers by N R Biermasz in
Google Scholar
PubMed
Search for other papers by O M Dekkers in
Google Scholar
PubMed
Search for other papers by F A Klok in
Google Scholar
PubMed
Search for other papers by N Reisch in
Google Scholar
PubMed
Search for other papers by A Aulinas in
Google Scholar
PubMed
Search for other papers by B Biagetti in
Google Scholar
PubMed
Search for other papers by S Cannavo in
Google Scholar
PubMed
Search for other papers by L Canu in
Google Scholar
PubMed
Search for other papers by M Detomas in
Google Scholar
PubMed
Search for other papers by F Devuyst in
Google Scholar
PubMed
Search for other papers by H Falhammar in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by F Ferrau in
Google Scholar
PubMed
Search for other papers by F Gatto in
Google Scholar
PubMed
Search for other papers by C Grasselli in
Google Scholar
PubMed
Search for other papers by P van Houten in
Google Scholar
PubMed
Search for other papers by C Hoybye in
Google Scholar
PubMed
Search for other papers by A M Isidori in
Google Scholar
PubMed
Search for other papers by A Kyrilli in
Google Scholar
PubMed
Search for other papers by P Loli in
Google Scholar
PubMed
Search for other papers by D Maiter in
Google Scholar
PubMed
Search for other papers by E Nowak in
Google Scholar
PubMed
Search for other papers by R Pivonello in
Google Scholar
PubMed
Search for other papers by O Ragnarsson in
Google Scholar
PubMed
Search for other papers by R V Steenaard in
Google Scholar
PubMed
Search for other papers by N Unger in
Google Scholar
PubMed
Search for other papers by A van de Ven in
Google Scholar
PubMed
Search for other papers by S M Webb in
Google Scholar
PubMed
Search for other papers by D Yeste in
Google Scholar
PubMed
University of Glasgow, Office for Rare Conditions, Glasgow, UK
University of Glasgow, Developmental Endocrinology Research Group, Royal Hospital for Children, Glasgow, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Search for other papers by A M Pereira in
Google Scholar
PubMed
(BMI ≥ 30 kg/m 2 ). A previous VTE (not related to CS based on the clinical judgment of the reporters, information on the time of occurrence was unavailable) was reported in 11 (4.9%) patients, and other cardiovascular events (e.g. myocardial infarction
Search for other papers by Clemens Kamrath in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany
Search for other papers by Alexander Eckert in
Google Scholar
PubMed
Search for other papers by Birgit Rami-Merhar in
Google Scholar
PubMed
Search for other papers by Sebastian Kummer in
Google Scholar
PubMed
Search for other papers by Martin Wabitsch in
Google Scholar
PubMed
Search for other papers by Katharina Laubner in
Google Scholar
PubMed
Search for other papers by Florian Kopp in
Google Scholar
PubMed
Search for other papers by Silvia Müther in
Google Scholar
PubMed
Search for other papers by Steffen Mühldorfer in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
progress to cirrhosis ( 14 , 15 ). Acute pancreatitis, liver disease (liver failure, gastrointestinal bleeding, hepatocellular carcinoma), and heart disease (cardiomyopathy, heart failure, myocardial infarction, arrhythmias) are major causes of mortality